We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

225 hedge funds and large institutions have $609M invested in Editas Medicine in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $9.68M

27% more capital invested

Capital invested by funds: $481M → $609M (+$128M)

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

2% more funds holding

Funds holding: 220 → 225 (+5)

1.21% less ownership

Funds ownership: 74.77% → 73.56% (-1.2%)

28% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 74

Holders
225
Holders Change
+5
Holders Change %
+2.27%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
53
Reduced
74
Closed
34
Calls
$13.5M
Puts
$9.68M
Net Calls
+$3.87M
Net Calls Change
+$1.26M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.5M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.06M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.07M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.88M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$20.8M
2
DTC
Deep Track Capital
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$9.51M
4
State Street
State Street
Massachusetts
-$6.16M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
126
Erste Asset Management
Austria
$155K – – –
Connor, Clark & Lunn Investment Management (CC&L)
127
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$148K +$128K +14,581 New
QT
128
Quantbot Technologies
New York
$146K +$126K +14,400 New
SPAS
129
Spectrum Planning & Advisory Services
California
$142K – – –
KFGK
130
Keystone Financial Group (Kentucky)
Kentucky
$142K – – –
Ohio Public Employees Retirement System (OPERS)
131
Ohio Public Employees Retirement System (OPERS)
Ohio
$137K +$119K +13,500 New
SPA
132
Sherbrooke Park Advisers
New York
$130K +$113K +12,853 New
AAS
133
Avantax Advisory Services
Texas
$128K +$6.27K +714 +6%
MML Investors Services
134
MML Investors Services
Massachusetts
$124K -$150K -17,078 -58%
Public Employees Retirement Association of Colorado
135
Public Employees Retirement Association of Colorado
Colorado
$118K – – –
CAN
136
Cetera Advisor Networks
California
$114K +$99K +11,277 New
CI Investments Inc
137
CI Investments Inc
Ontario, Canada
$114K +$4.77K +543 +5%
Victory Capital Management
138
Victory Capital Management
Texas
$111K +$95.9K +10,925 New
TCM
139
Teza Capital Management
Illinois
$110K +$95.3K +10,857 New
BAM
140
Brave Asset Management
New Jersey
$109K – – –
KOC
141
Koss-Olinger Consulting
Florida
$101K – – –
CUAMC
142
China Universal Asset Management Company
China
$95.7K +$64.6K +7,355 +351%
VEA
143
Virtus ETF Advisers
New York
$86.5K -$3.27K -373 -4%
AIP
144
Ameritas Investment Partners
Nebraska
$83.5K – – –
AB
145
Amalgamated Bank
New York
$79K -$2.33K -265 -3%
Daiwa Securities Group
146
Daiwa Securities Group
Japan
$77K -$5.97K -680 -8%
TRCT
147
Tower Research Capital (TRC)
New York
$65.2K -$127K -14,477 -69%
Russell Investments Group
148
Russell Investments Group
United Kingdom
$52.6K +$36.5K +4,156 +402%
MLICM
149
Metropolitan Life Insurance Company (MetLife)
New York
$48.7K – – –
Lazard Asset Management
150
Lazard Asset Management
New York
$47K +$1.62K +185 +4%
4 5
6
7 8

EDIT Hedge Fund Activity: Q4 2023 in Review

225 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2023, worth a combined $609M — up 27% from $481M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 34 closed out — a net gain of 5 holders — while 53 added to existing stakes and 74 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.5M. The largest seller was Woodline Partners, cutting an estimated $20.8M.

  • 225 institutional investors held Editas Medicine (EDIT) as of Q4 2023, up from 220 in Q3 2023.
  • Funds reported $609M of Editas Medicine stock for Q4 2023, up 27% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2023 and 34 closed out, a net change of +5 holders.
  • The largest Editas Medicine buyer in Q4 2023 was Morgan Stanley, an estimated $10.5M added.
  • The largest Editas Medicine seller in Q4 2023 was Woodline Partners, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2023.